Werfel Asked To Clarify How To Treat R&D Costs In M&A <https://www.law360.com/mergersacquisitions/articles/1878275?nl_pk=a34c25b5-f021-4515-a5f9-06e53584a502&utm_source=newsletter&utm_medium=email&utm_campaign=mergersacquisitions&utm_content=2024-09-11&read_main=1&nlsidx=0&nlaidx=5> By Law360 Staff Accounting firm RSM US LLP, in a letter released Tuesday, asked Internal Revenue Commissioner Daniel Werfel to clarify how to treat research and development costs when a taxpayer disposes of an entire business in a mergers and acquisitions transaction. Letter attached | Read full article » <https://www.law360.com/mergersacquisitions/articles/1878275?nl_pk=a34c25b5-f021-4515-a5f9-06e53584a502&utm_source=newsletter&utm_medium=email&utm_campaign=mergersacquisitions&utm_content=2024-09-11&read_more=1&nlsidx=0&nlaidx=5> | Save to favorites » <https://www.law360.com/mergersacquisitions/articles/1878275?nl_pk=a34c25b5-f021-4515-a5f9-06e53584a502&utm_source=newsletter&utm_medium=email&utm_campaign=mergersacquisitions&utm_content=2024-09-11&read_later=1&nlsidx=0&nlaidx=5>